Table 5.
Individual frailty components associated with Clavien IV complications
| Univariable | Multivariable | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p value | OR | 95% CI | p value | |
| Dependent functional status (vs independent) | 6.49 | 5.03–8.35 | < 0.001 | 4.28 | 3.21–5.71 | < 0.001 |
| Diabetes mellitus | 2.65 | 2.07–3.40 | < 0.001 | 1.42 | 1.07–1.87 | 0.013 |
| Hypertension | 3.61 | 2.78–4.68 | < 0.001 | 2.45 | 1.85–3.25 | < 0.001 |
| Congestive heart failure | 5.49 | 3.19–9.43 | < 0.001 | 1.80 | 0.97–3.31 | 0.061 |
| History of MI within 6 months | 3.30 | 1.56–6.99 | 0.001 | 1.36 | 0.59–3.12 | 0.471 |
| History of PCI/CS/angina | 1.99 | 1.38–2.87 | < 0.001 | 1.07 | 0.62–1.60 | 0.726 |
| COPD or pneumonia | 3.40 | 2.36–4.91 | < 0.001 | 1.80 | 1.21–2.68 | 0.004 |
| Peripheral vascular disease | 3.15 | 1.74–5.69 | < 0.001 | 1.09 | 0.57–2.07 | 0.791 |
| Impaired sensorium | 5.48 | 3.19–9.43 | < 0.001 | 1.55 | 0.85–2.83 | 0.155 |
| TIA/CVA without residual deficit | 2.80 | 1.69–4.63 | < 0.001 | 1.38 | 0.80–2.36 | 0.244 |
| CVA/stroke with residual deficit | 3.07 | 1.91–4.91 | < 0.001 | 0.86 | 0.51–1.44 | 0.561 |
MI myocardial infarction, PCI percutaneous coronary intervention, CS cardiac surgery, COPD chronic obstructive pulmonary disease, TIA transient ischemic attack, CVA cerebrovascular accident; italic font represents statistically significant associations